A1R deletion reduced human melanoma cell line and tumor growth in immune-deficient xenografts, upregulated PD-L1 levels, and inactivated co-cultured T cells, which compromised anti-tumor immunity in vivo (330), indicating the critical role of ARs in the anti-tumor immune response. This evidence concerns the gene CD274 and neoplasm.